Stroke study reveals key target for improving treatment and suggests that Gleevec may help
Sunday, June 22, 2008 - 14:07
in Health & Medicine
Research in mice shows why tPA carries risks as well as benefits, and suggests that Gleevec or other drugs could prevent problems For over a decade, the drug called tPA has proven its worth as the most effective emergency treatment for the most common kind of stroke. But its promise is blemished by two facts: tPA can cause dangerous bleeding in the brain, and its brain-saving power fades fast after the third hour of a stroke.